Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Source: cnbc.com
Page 8 - Michael Yee News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Yee Today - Breaking & Trending Today
Moderna (MRNA) Q1 2024 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2024.
Source: yahoo.com
Moderna (MRNA) Q1 2024 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2024.
Source: fool.com
Amgen investors await weight-loss drug data
Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-loss drug candidates when it reports quarterly earnings on Thursday. Amgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting and analyzing the data," Amgen Chief Scientific Officer Jay Bradner told Reuters in an interview.
Source: yahoo.com
Amgen investors await weight-loss drug data
By Deena Beasley (Reuters) - Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-loss drug candidates when it reports quarterly ...
Source: wsau.com